Jacobs Levy Equity Management, Inc G1 Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.2 - $4.98 $188,617 - $426,960	85,735 Added 22.69%	463,593 $1.06 Million
Q1 2024 May 15, 2024	BUY	$2.1 - $4.83 $136,059 - $312,935	64,790 Added 20.7%	377,858 $1.63 Million
Q4 2023 Feb 14, 2024	SELL	$1.12 - $3.73 $291,410 - $970,501	-260,188 Reduced 45.39%	313,068 $954,000
Q3 2023 Nov 16, 2023	BUY	$1.22 - $2.67 $98,185 - $214,881	80,480 Added 16.33%	573,256 $825,000
Q2 2023 Aug 14, 2023	BUY	$2.46 - $3.14 $515,470 - $657,958	209,541 Added 73.98%	492,776 $1.23 Million
Q1 2023 May 15, 2023	BUY	$2.57 - $8.16 $488,785 - $1.55 Million	190,189 Added 204.4%	283,235 $759,000
Q4 2022 Feb 14, 2023	SELL	$5.19 - $13.5 $49,159 - $127,872	-9,472 Reduced 9.24%	93,046 $505,000
Q3 2022 Nov 15, 2022	SELL	$5.17 - $16.99 $1.57 Million - $5.16 Million	-303,546 Reduced 74.75%	102,518 $1.28 Million
Q2 2022 Aug 15, 2022	BUY	$4.04 - $8.51 $1.64 Million - $3.46 Million	406,064 New	406,064 $2.01 Million
Q3 2021 Nov 15, 2021	SELL	$13.16 - $22.47 $144,615 - $246,922	-10,989 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$19.57 - $26.32 $553,772 - $744,777	-28,297 Reduced 72.03%	10,989 $241,000
Q1 2021 May 17, 2021	SELL	$17.58 - $32.59 $1.56 Million - $2.89 Million	-88,797 Reduced 69.33%	39,286 $945,000
Q4 2020 Feb 16, 2021	BUY	$10.99 - $20.4 $52,576 - $97,593	4,784 Added 3.88%	128,083 $2.3 Million
Q3 2020 Nov 16, 2020	BUY	$11.55 - $23.75 $774,323 - $1.59 Million	67,041 Added 119.17%	123,299 $1.42 Million
Q2 2020 Aug 17, 2020	BUY	$9.57 - $24.37 $220,779 - $562,215	23,070 Added 69.51%	56,258 $1.37 Million
Q1 2020 May 15, 2020	BUY	$9.07 - $26.32 $215,512 - $625,389	23,761 Added 252.05%	33,188 $366,000
Q4 2019 Feb 14, 2020	BUY	$20.54 - $31.0 $193,630 - $292,237	9,427 New	9,427 $249,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account